Product Overview
CDK9-IN-2 | T14918 | TargetMol Chemicals
CAS: 1263369-28-3
Smiles: N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCc2cccc(F)c2)n1
Formula: C23H25ClFN5
Pathway: Cell Cycle/Checkpoint|||Others
Target: Others|||CDK
Receptor: N/A
Bioactivity: CDK9-IN-2 is a special CDK9 inhibitor extracted from patent WO/2012131594A1 (compound CDKI(8)) and has an IC50 of 5 nM and 7 nM in A2058 skin cell line (72 hours) and H929 multiple myeloma cell line (72 hours), respectively.
Molecular Weight: 425, 94
![2-[2-(2, 2, 2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/500x659/products/47546/44202/TargetMol-768x384__12443.1665998863__94292.1666031974.png?c=1 "2-[2-(2, 2, 2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate")
![N-(2-{bis[2-(2, 2-dichloroacetamido)ethyl]amino}ethyl)-2, 2-dichloroacetamide hydrochloride](https://cdn11.bigcommerce.com/s-2kvb5rm600/images/stencil/500x659/products/42847/39503/TargetMol-768x384__12443.1665998863__78173.1666025620.png?c=1 "N-(2-{bis[2-(2, 2-dichloroacetamido)ethyl]amino}ethyl)-2, 2-dichloroacetamide hydrochloride")